Purpureaside C
Based on 1 Customer Validation
Purpureaside C, phenolic glycoside, is a minichromosome maintenance complex component 6 (MCM6) inhibitor. Purpureaside C binds to the ATP-pocket of MCM6, suppresses MCM6 protein expression in gastric cancer cells. Purpureaside C suppresses gastric cancer cell growth and induces apoptosis. Purpureaside C exerts antibacterial activity and proinflammatory activity. Purpureaside C can be used for the researches of gastric cancer, bacterial infection and inflammation.
Nur für Forschungszwecke. Wir verkaufen nicht an Patienten.
- Reinheit: 99.40%
- CAS. Nr.: 108648-07-3
- Formel: C35H46O20
- Molecular Weight:786.73
-
Speicherung:Powder -20°C, 3 years , 4°C, 2 years ; In solvent -80°C, 6 months , -20°C, 1 month
To place orders, for customer services and technical support, please contact: MedChemExpress USA
Tel: 609-228-6898 E-mail: [email protected] [email protected]
-
Biologische Aktivität
-
Chemical Information
-
Lösungsmittel & Löslichkeit
- Reinheit & Dokumentation
- Verweise
-
Help & FAQs
Alle DNA/RNA Synthesis Isoform-spezifische Produkte anzeigen
More
Biologische Aktivität
Purpureaside C binds to the ATP-pocket of human MCM6 protein with a docking score of -11.804, indicating strong predicted binding affinity[1].
Purpureaside C (20-50 μM; 48 h) dose-dependently suppresses MCM6 protein expression in MGC-803, SGC-7901, and BGC-823 human gastric cancer cell lines[1].
Purpureaside C (10-40 μM; 48 h) inhibits cell viability in MGC-803, SGC-7901, and BGC-823 human gastric cancer cell lines[1].
Purpureaside C (20-40 μM; 48 h) dose-dependently reduces colony-forming capacity in MGC-803, SGC-7901, and BGC-823 human gastric cancer cell lines[1].
Purpureaside C synergizes with 5-Fluorouracil (HY-90006) to inhibit growth and induces apoptosis in MGC-803 and SGC-7901 human gastric cancer cell lines[1].
Purpureaside C exhibits weak in vitro antibacterial activity against Escherichia coli, decreases multiple in vitro human leukocyte functions including rosette formation, mitogen-induced blast transformation, and phagocytic activity and shows significant proinflammatory activity[2].
MedChemExpress (MCE) has not independently confirmed the accuracy of these methods. They are for reference only.
-
Cell Line:MGC-803, SGC-7901, BGC-823 human gastric cancer cell lines
-
Concentration:20, 40 μM (MGC-803, SGC-7901); 25, 50 μM (BGC-823)
-
Incubation Time:48 h
-
Result:Suppressed MCM6 protein expression in a dose-dependent manner across all three cell lines.
Reduced MCM6/β-actin ratios to 0.58 and 0.29 at 20 and 40 μM respectively in MGC-803 cells.
Reduced MCM6/β-actin ratios to 0.51 and 0.21 at 20 and 40 μM respectively in SGC-7901 cells.
Reduced MCM6/β-actin ratios to 0.63 and 0.28 at 25 and 50 μM respectively in BGC-823 cells.
Chemical Information
-
CAS. Nr. 108648-07-3
-
Appearance Solid
-
Molecular Weight 786.73
-
Formel C35H46O20
-
Color White to yellow
-
SMILES
OC1=C(O)C=CC(/C=C/C(O[C@H]2[C@@H]([C@H]([C@H](OCCC3=CC(O)=C(O)C=C3)O[C@@H]2CO[C@@H]4O[C@@H]([C@H](O)[C@H](O)[C@H]4O)CO)O)O[C@@]5([H])[C@@H]([C@@H]([C@@H](O)[C@H](C)O5)O)O)=O)=C1
-
Structure Classification
-
Versand
Room temperature in continental US; may vary elsewhere.
-
Speicherung
Powder -20°C 3 years 4°C 2 years In solvent -80°C 6 months -20°C 1 month
Lösungsmittel & Löslichkeit
DMSO : 125 mg/mL (158.89 mM; Need ultrasonic; Hygroscopic DMSO has a significant impact on the solubility of product, please use newly opened DMSO)
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
Konzentration (Stammlösung) × Volumen (Stammlösung) = Konzentration (Ziellösung) × Volumen (Ziellösung)
Select the appropriate dissolution method based on your experimental animal and administration route.
- For the following dissolution methods, please ensure to first prepare a clear stock solution using an In Vitro approach and then sequentially add co-solvents:
- To ensure reliable experimental results, the clarified stock solution can be appropriately stored based on storage conditions. As for the working solution for In Vivo experiments, it is recommended to prepare freshly and use it on the same day.
- The percentages shown for the solvents indicate their volumetric ratio in the final prepared solution. If precipitation or phase separation occurs during preparation, heat and/or sonication can be used to aid dissolution.
Add each solvent one by one: 10% DMSO 40% PEG300 5% Tween-80 45% Saline
Solubility: ≥ 2.08 mg/mL (2.64 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 400 μL PEG300, and mix evenly; then add 50 μL Tween-80 and mix evenly; then add 450 μL Saline to adjust the volume to 1 mL.
Preparation of Saline: Dissolve 0.9 g sodium chloride in ddH₂O and dilute to 100 mL to obtain a clear Saline solution.
Add each solvent one by one: 10% DMSO 90% (20% SBE-β-CD in Saline)
Solubility: ≥ 2.08 mg/mL (2.64 mM); Clear solution
This protocol yields a clear solution of ≥ 2.08 mg/mL (saturation unknown).
Taking 1 mL working solution as an example, add 100 μL DMSO stock solution (20.8 mg/mL) to 900 μL 20% SBE-β-CD in Saline, and mix evenly.
Preparation of 20% SBE-β-CD in Saline (4°C, storage for one week): 2 g SBE-β-CD powder is dissolved in 10 mL Saline, completely dissolve until clear.
Please enter the basic information of animal experiments:
-
-
-
-
Recommended: Prepare an additional quantity of animals to account for potential losses during experiments.
Please enter your animal formula composition:
-
%DMSO +
Recommended: Keep the proportion of DMSO in working solution below 2% if your animal is weak.
-
%+
-
+%Tween-80 + +
-
%Saline +
The co-solvents required include: DMSO, . All of co-solvents are available by MedChemExpress (MCE). , Tween 80. All of co-solvents are available by MedChemExpress (MCE).
Working solution concentration: 0.22 mg/mL
Method for preparing stock solution: mg drug dissolved in μL DMSO. Stock solution concentration: mg/mL.
1. Take μL DMSO stock solution;
2. Add μL .
μL , mix evenly;
3. Then add μL Tween 80, mix evenly;
4. Then add μL
Please ensure that the stock solution in the first step is dissolved to a clear state, and add co-solvents in sequence. You can use ultrasonic heating (ultrasonic cleaner, recommended frequency 20-40 kHz), vortexing, etc. to assist dissolution.
Reinheit & Dokumentation
-
Data Sheet (279 KB)
-
SDS (251 KB)
- English - EN (251 KB)
- Français - FR (251 KB)
- Deutsch - DE (251 KB)
- Norwegian - NO (251 KB)
- Español - ES (251 KB)
- Swedish - SV (251 KB)
- Italian - IT (251 KB)
- Korean - KR (251 KB)
- Portuguese - PT (251 KB)
-
Handling Instructions (2659 KB)
Verweise
[1]. Wang Y, et al. MCM6 is a critical transcriptional target of YAP to promote gastric tumorigenesis and serves as a therapeutic target. Theranostics. 2022;12(15):6509-6526. Published 2022 Sep 6. [Content Brief]
[2]. Molnár J, et al. Antimicrobial and immunomodulating effects of some phenolic glycosides. Acta Microbiol Hung. 1989;36(4):425-32. [Content Brief]
Complete Stock Solution Preparation Table
Please refer to the solubility information to select the appropriate solvent. Once prepared, please aliquot and store the solution to prevent product inactivation from repeated freeze-thaw cycles.
Storage method and period of stock solution: -80°C, 6 months; -20°C, 1 month. When stored at -80°C, please use it within 6 months. When stored at -20°C, please use it within 1 month.
| Optional Solvent | Concentration Solvent Mass | 1 mg | 5 mg | 10 mg | 25 mg |
|---|---|---|---|---|---|
| DMSO | 1 mM | 1.2711 mL | 6.3554 mL | 12.7108 mL | 31.7771 mL |
| 5 mM | 0.2542 mL | 1.2711 mL | 2.5422 mL | 6.3554 mL | |
| 10 mM | 0.1271 mL | 0.6355 mL | 1.2711 mL | 3.1777 mL | |
| 15 mM | 0.0847 mL | 0.4237 mL | 0.8474 mL | 2.1185 mL | |
| 20 mM | 0.0636 mL | 0.3178 mL | 0.6355 mL | 1.5889 mL | |
| 25 mM | 0.0508 mL | 0.2542 mL | 0.5084 mL | 1.2711 mL | |
| 30 mM | 0.0424 mL | 0.2118 mL | 0.4237 mL | 1.0592 mL | |
| 40 mM | 0.0318 mL | 0.1589 mL | 0.3178 mL | 0.7944 mL | |
| 50 mM | 0.0254 mL | 0.1271 mL | 0.2542 mL | 0.6355 mL | |
| 60 mM | 0.0212 mL | 0.1059 mL | 0.2118 mL | 0.5296 mL | |
| 80 mM | 0.0159 mL | 0.0794 mL | 0.1589 mL | 0.3972 mL | |
| 100 mM | 0.0127 mL | 0.0636 mL | 0.1271 mL | 0.3178 mL |
Purpureaside C Related Classifications
HY-N4148 Related Classifications
Powered by Bioz